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Cyclic adenosine monophosphate (cAMP) has been implicated as an important regulator of meiotic maturation in
mammalian oocytes. A decrease in cAMP, brought about by the action of cAMP phosphodiesterase (PDE), is thought to
initiate germinal vesicle breakdown (GVB) by the inactivation of cAMP-dependent protein kinase. However, the product of
PDE activity, 5-AMP, is a potent activator of an important regulatory enzyme, AMP-activated protein kinase (AMPK). The
aim of this study was to evaluate a possible role for AMPK in meiotic induction, using oocytes obtained from eCG-primed,
immature mice. Alpha-1 and -2 isoforms of the catalytic subunit of AMPK were detected in both oocytes and cumulus cells.
When 5-aminoimidazole-4-carboxamide 1--D-ribofuranoside (AICA riboside), an activator of AMPK, was tested on denuded
oocytes (DO) and cumulus cell-enclosed oocytes (CEO) maintained in meiotic arrest by dbcAMP or hypoxanthine, GVB was
dose-dependently induced. Meiotic induction by AICA riboside in dbcAMP-supplemented medium was initiated within 3 h
in DO and 4 h in CEO and was accompanied by increased AMPK activity in the oocyte. AICA riboside also triggered GVB
when meiotic arrest was maintained with hypoxanthine, 8-AHA-cAMP, guanosine, or milrinone, but was ineffective in
olomoucine- or roscovitine-arrested oocytes, indicating that it acts upstream of maturation-promoting factor. Adenosine
monophosphate dose-dependently stimulated GVB in DO when meiotic arrest was maintained with dbcAMP or
hypoxanthine. This effect was not mimicked by other monophosphate or adenosine nucleotides and was not affected by
inhibitors of ectophosphatases. Combined treatment with adenosine and deoxycoformycin, an adenosine deaminase
inhibitor, stimulated GVB in dbcAMP-arrested CEO, suggesting AMPK activation due to AMP accumulation. It is
concluded that phosphodiesterase-generated AMP may serve as a transducer of the meiotic induction process through
activation of AMPK. © 2002 Elsevier Science (USA)
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Mammalian oocyte maturation within healthy, non-
atretic ovarian follicles is triggered by gonadotropin at the
time of the preovulatory hormonal surge. However, when
meiotically competent germinal vesicle-stage oocytes are
removed from mature follicles and cultured in vitro in a
suitable medium, they spontaneously resume meiotic
maturation without hormone mediation. This observation,
originally reported by Pincus and Enzmann (1935) and since
confirmed by numerous laboratories (see Tsafriri and
Dekel, 1994; Downs, 1995a for reviews), suggested that the
follicle provides an inhibitory influence that holds the
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200competent oocyte in meiotic arrest until the proper
meiosis-inducing signal is delivered. One compound
thought to play a critical role in this regard is cyclic
adenosine monophosphate (cAMP). Evidence indicates that
cAMP levels within the oocyte dictate meiotic status such
that high levels maintain meiotic arrest while lower levels
are permissive for reinitiation of meiotic maturation as
manifested by germinal vesicle breakdown (GVB).
The action of cAMP in oocytes is mediated by cAMP-
dependent protein kinase (PKA). cAMP binds to the regula-
tory subunits of PKA, thereby releasing the active catalytic
subunits to phosphorylate serine or threonine residues on
protein substrates. It has been shown by the use of site-
selective cAMP analogs that different PKA isoforms are
involved in opposing functions of meiotic regulation in the
germ and somatic cell compartments of the follicle. Type I
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PKA mediates the inhibitory action of cAMP in the oocyte,
while type II mediates the meiosis-inducing pulse of cAMP
that occurs within the cumulus granulosa cells following
hormonal stimulation (Downs and Hunzicker-Dunn, 1995).
Moreover, oocytes maintained in meiotic arrest by elevated
cAMP can be induced to resume maturation by microinjec-
tion of PKA inhibitors (Bornslaeger et al., 1986; Eppig,
1989).
An important enzyme controlling PKA activity is cAMP
phosphodiesterase (PDE). This enzyme cleaves the phos-
phodiester bond of cAMP to form 5-AMP that can no
longer bind to the regulatory subunit of PKA to activate it.
PDE activity is present within oocytes (Bornslaeger et al.,
1984; Downs et al., 1989), and its action is responsible for
lowering cAMP levels and permitting spontaneous matura-
tion, presumably by the loss of PKA activity. This is readily
demonstrated by the use of established PDE inhibitors that
maintain elevated cAMP levels and coincidentally block
spontaneous maturation (Cho et al., 1974; Magnusson and
Hillensjo, 1977; Dekel et al., 1981; Vivarelli et al., 1983).
Hormone-induced maturation in situ also apparently re-
quires a drop in oocyte cAMP. Using inhibitors of the
oocyte-specific isoform of PDE, Wiersma et al. (1998) re-
ported the ovulation of immature, germinal vesicle-stage
oocytes in a superovulated rat model. This exciting result
not only showed that ovulation and meiotic maturation are
separable phenomena but also that PDE is required in the
events preceding meiotic resumption.
The model that has emerged for meiotic regulation in
mammalian ovarian follicles has cAMP, PDE, and PKA as
pivotal components. According to this scheme, cAMP,
generated either locally or transferred to the oocyte from
the somatic compartment via gap junctions, binds to and
activates PKA, thereby maintaining meiotic arrest. A PDE-
mediated drop in cAMP inactivates PKA and eliminates the
meiosis-arresting influence, allowing meiotic resumption.
Thus, the activity of PKA within the oocyte is directly
linked to meiotic arrest, with maturation occurring by a
“disinhibition” mechanism. However, the transduction
system by which the somatic compartment signals the
oocyte to trigger meiotic resumption following the preovu-
latory gonadotropin surge is not well understood.
Although considerable evidence supports cAMP-
dependent meiotic arrest, conditions exist whereby mam-
malian oocyte maturation can apparently occur without a
preceding drop in oocyte cAMP. For example, cumulus
cell-enclosed oocytes maintained in meiotic arrest with
cAMP analogs or phosphodiesterase inhibitors can be
stimulated to resume meiotic maturation with gonadotro-
pin, despite the continued presence of the arresting agent
(Dekel and Beers, 1978; Downs et al., 1988). Thus, it is
unlikely that, prior to GVB, oocyte cAMP falls below the
basal level present at the time of isolation; rather, a positive
meiotic trigger appears to bypass meiosis-arresting levels of
cAMP. Indeed, studies from several vertebrate species,
including sheep (Moor and Heslop, 1981), hamster (Ra-
cowsky, 1985a; Hubbard, 1986), rabbit (Yoshimura et al.,
1992a,b), pig (Racowsky, 1985b; Mattioli et al., 1994),
mouse (Salustri et al., 1985; Hashimoto et al., 1985), and
frog (Gelerstein et al., 1989), have reported that meiotic
resumption can occur without a measurable decline in
oocyte cAMP below basal levels. In fact, meiotic matura-
tion in some invertebrate species actually requires an
increase in oocyte cAMP (Yamashita, 1988; Freeman and
Ridgway, 1988; Stricker and Smythe, 2001). Hence, these
studies suggest that alternative, or additional, mechanisms
exist other than reduced cAMP levels to bring about mei-
otic resumption.
One possible mechanism incorporates a more proactive
involvement of PDE. As mentioned above, PDE converts
cAMP to 5-AMP, a compound that has been largely ignored
in oocyte physiology, presumed to be an inactive byproduct
of the enzyme in oocytes. However, it is important to note
that AMP is a potent regulator of a serine/threonine kinase
termed AMP-activated protein kinase, or AMPK (for re-
views, see Hardie and MacKintosh, 1992; Hardie and
Carling, 1997; Winder and Hardie, 1999). AMPK is a mem-
ber of the AMPK/SNF1 protein kinase family, whose mem-
bers can be found in a diverse array of organisms (e.g.,
mammals, plants, and yeast) and are typically activated in
response to nutritional and environmental stress. AMPK
controls the activity of important rate-limiting enzymes of
carbohydrate and fat metabolism (Hardie, 1992; Hardie and
Carling, 1997; Hardie et al., 1998; Merrill et al., 1997, 1998),
acting as a type of “fuel gauge” in response to changes in
cellular energy charge (Hardie and Carling, 1997). Thus, as
a result of stresses such as heat shock or arsenite (Corton et
al., 1994), high fructose (Moore et al., 1991), ischemia (Kudo
et al., 1995) or exercise (Winder and Hardie, 1996), which
compromise cellular energy levels, AMPK becomes acti-
vated, and one function is to shut down fatty acid and
cholesterol synthesis. In general, activation of AMPK
switches off anabolic pathways of lipid and carbohydrate
metabolism and switches on the corresponding catabolic
pathways, in order both to conserve ATP and generate
more. It achieves this both via direct phosphorylation of
metabolic enzymes and via indirect effects on gene expres-
sion (Winder and Hardie, 1999; Hardie and Hawley, 2001).
AMPK is a heterotrimeric protein with a catalytic 
subunit and  and  regulatory subunits, and its activity is
sensitively controlled within cells by the AMP/ATP ratio
(Hardie et al., 1999). Since the level of ATP in cells is in the
millimolar range, while that of AMP is much lower, small
increases in AMP or larger decreases in ATP significantly
increase the AMP/ATP ratio and bring about activation of
the enzyme (Hardie and MacKintosh, 1992). AMP activates
AMPK both allosterically and by promoting its phosphory-
lation by an upstream kinase. An intriguing possibility is
that PDE activity within oocytes generates enough AMP
from cAMP degradation to activate AMPK that, in turn,
provides a positive stimulus for oocyte maturation. Indeed,
using differential display analysis of cDNA libraries pre-
pared from mouse eggs, Heyer et al. (1997, 1999) have
identified a novel kinase, Melk, that is a member of the
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AMPK/SNF1 family and have proposed an important role
for the kinase in signal transduction events during develop-
ment.
We have tested the hypothesis that stimulation of AMPK
within the oocyte participates in the mechanism control-
ling meiotic resumption. Using Western analysis, enzyme
assays, and activators of the enzyme, we demonstrate the
presence of AMPK in mouse oocytes and show that its
activity is associated with meiotic induction.
MATERIALS AND METHODS
Oocyte Isolation and Culture Conditions
Immature C57BL/6J  SJL/J F1 mice, 20–23 days old, were used
for all experiments. Mice were primed with 5 IU equine chorionic
gonadotropin and killed 48 h later by cervical dislocation. Ovaries
were removed and placed in culture medium, and large antral
follicles were punctured with sterile needles. Cumulus cell-
enclosed oocytes (CEO) were collected, washed through two to
three additional changes of medium, and transferred in a small
volume to plastic culture tubes (Falcon 2058) or stoppered borosili-
cate glass tubes containing 1 ml of the appropriate culture medium.
Denuded oocytes (DO) were prepared by repeated pipetting with a
Pasteur pipet. Tubes were gassed with a humidified mixture of 5%
CO2, 5% O2, and 90% N2 and placed in a water bath at 37°C for the
duration of culture. The medium used in this study was Eagle’s
minimum essential medium supplemented with 0.23 mM pyru-
vate, penicillin, streptomycin sulphate, and 3 mg/ml crystallized
lyophilized bovine serum albumin (ICN ImmunoBiologicals, Lisle,
IL)
AMP Uptake
DO were cultured in medium containing 10 Ci [2-3H] adeno-
sine monophosphate (21.0 Ci/mmol; Amersham Life Sciences, Inc.,
Arlington Heights, IL). At the end of culture, oocytes from each
treatment group were washed through three changes of PBS/BSA to
remove external radiolabel and 25 were transferred to a scintilla-
tion vial. Radioactivity was determined after addition of 5 ml
scintillation fluid. An equal volume of buffer from the last wash
dish for each group served as a blank.
AMPK Assay
DO were cultured 4 h in medium containing dbcAMP alone or
dbcAMP plus 250 or 500 m AICA riboside. Oocytes were then
washed several times in immunoprecipitation buffer [50 mM
Tris/HCl, pH 7.4 at 4°C, 150 mM NaCl, 5 mM Na pyrophosphate,
50 mM NaF, 1 mM EGTA, 1 mM EDTA, 1 mM dithiothreitol
(DTT)] containing 3 mg/ml polyvinylpyrrollidone and stored frozen
in this buffer at80°C until assayed. AMPK activity was measured
by using a method adapted from Hardie et al. (2000). Briefly, frozen
oocytes were diluted twofold into immunoprecipitation buffer
containing 2% (v/v) Triton X-100, 2 mM benzamidine, 2 mM
PMSF, 10 g/ml soybean trypsin inhibitor and vortexed until
completely thawed. AMPK was immunoprecipitated by using
protein G-Sepharose coupled to a mixture of affinity-purified sheep
antibodies raised against the 1 and 2 isoforms of the catalytic
subunits of AMPK (Woods et al., 1996). The final pellet was diluted
threefold into Hepes–Brij buffer (50 mM Na Hepes, pH 7.4, 1 mM
DTT, 0.02% Brij-35) prior to assay in reaction mixture [0.2 mM
[-32P]ATP (specific activity 250–500 cpm/pmol), 5 mM MgCl2, 0.2
mM AMP in Hepes–Brij buffer, 0.2 mM AMARA peptide (AMA-
RAASAAASARRR) in Hepes–Brij buffer] at 30°C for 30 min.
Aliquots corresponding to 3/5 of the reaction mixture were then
spotted onto P81 paper (Whatman) and the reactions stopped with
1% (v/v) phosphoric acid. Radioactivity was measured by liquid
scintillation counting. Blank values were determined by omitting
the peptide substrate from the assay. AMPK activity is expressed in
units of nmole phosphate incorporated into substrate peptide per
minute.
Western Analysis of  Subunits of AMPK
DO and oocyte-cumulus cell complexes (OCC) were obtained
from primed mice, washed in immunoprecipitation buffer (see
above), and stored frozen in this buffer at 80°C until used for
Western blotting. Prior to gel electrophoresis, the oocytes were
homogenized by using a motorized pellet pestle (Sigma) and con-
centrated in 1.5 ml vivaspins (Vivascience Ltd.; 30,000 mw cut-off).
The proteins were electrophoresed on 10% (w/v) polyacrylamide/
SDS gels and transferred to nitrocellulose membranes. Blots were
probed first with an affinity purified sheep antibody raised against
either the 1 or 2 isoform of the catalytic subunit of AMPK (0.3
g/ml) and then with protein G coupled to horseradish peroxidase
(0.2 g/ml; Sigma). Protein G binding was detected by using
enhanced chemiluminescence reagents (ECL; Amersham Pharma-
cia).
Chemicals
All culture medium components, AICA riboside, dbcAMP, hypo-
xanthine, 8-aminohexylamino-cAMP, 8-bromo-cAMP, guanosine,
milrinone, 5-aminodeoxyadenosine, forskolin, olomoucine, roscovi-
tine, ,-methylene ADP, -glycerophosphate, and nucleotides were
obtained from Sigma Chemical Co. (St. Louis, MO). Deoxycoformycin
was the kind gift of SuperGen, Inc. (San Ramon, CA).
Statistical Analysis
Oocyte maturation experiments were repeated at least 3 times
with at least 30 oocytes per group per experiment. In all cases,
viability was maintained at greater than 93%, which is considered
normal (Downs and Mastropolo, 1997). Oocyte maturation fre-
quencies were subjected to arcsin transformation, and groups of
three or more were analyzed statistically by ANOVA followed by
Duncan’s multiple range test, while paired comparisons were made
with Student’s t test. Nontransformed data from AMPK assays
were analyzed by Student’s t test. For all statistical analyses, a P
value less than 0.05 was considered significant.
RESULTS
Western Analysis of Oocytes and OCC
Western analysis was carried out by using affinity puri-
fied antibodies to identify the AMPK catalytic subunit
isoforms in extracts of oocytes and OCC. The equivalent of
200 OCC and 1000 oocytes was loaded in each lane. As
shown in Fig. 1, oocytes contain both -1 and -2 subunit
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isoforms, and since the labeled bands are more intense in
the lanes loaded with complex extracts, it can be concluded
that cumulus cells contain both isoforms as well. It is also
apparent that the ratio of the amount of subunit in cumulus
cells to that in the oocyte is much higher for the -1 isoform
than for the -2 isoform. The -1 subunit from the OCC
appeared to migrate as multiple bands, possibly a doublet.
This is frequently observed for AMPK  subunits and
appears to be due to autophosphorylation at multiple sites
(Hawley et al., 1996) and/or multiple phosphorylation by
the upstream kinase (Stein et al., 2000).
AICA Riboside and Oocyte Maturation
5-Aminoimidazole-4-carboxamide 1--D-ribofuranoside
(AICA riboside) is an adenosine analog that enters cells and
is phosphorylated by adenosine kinase to form the AMP
analog, AICA ribotide (ZMP), an intermediate in the purine
de novo pathway (see Fig. 2), but also a potent stimulator of
AMPK. AICA riboside is the principle pharmacological
agent used to increase AMPK activity in a wide variety of
cells and provides a means of activating AMPK without
affecting AMP or ATP levels (Sullivan et al., 1994; Corton
et al., 1995; Henin et al., 1995). It has been utilized herein
to test for a meiosis-inducing action in arrested oocytes.
DO and CEO were cultured 17–18 h in medium contain-
ing 300 M dbcAMP or 4 mM hypoxanthine plus increasing
concentrations of AICA riboside before meiotic assessment.
In the presence of either inhibitor, AICA riboside increased
the frequency of meiotic maturation in a dose-dependent
fashion, regardless of the presence or absence of cumulus
cells, although it was more potent in DO. In control
cultures, DO resumed maturation at a frequency of 5–12%,
and the addition of 250 M AICA riboside increased this to
91–94% (Fig. 3A). In CEO, lower concentrations (50–250
M) were either slightly inhibitory or had no effect, but
higher concentrations proved to be stimulatory, with com-
plete meiotic induction at 1000 M (Fig. 3B).
To test the time course of meiotic induction, DO and
CEO were cultured for varying periods in medium contain-
ing 300 M dbcAMP  250 (DO) or 1000 M (CEO) AICA
riboside. Although AICA riboside had no effect in either
DO or CEO after 2 h, significant stimulation of GVB was
observed in DO after only 3 h, with a 56.2% increase in
GVB after 4 h (Fig. 4). Meiotic induction was slower in CEO,
with a comparable increase in GVB requiring more than 6 h
of incubation.
To determine whether these rapid kinetics of meiotic
induction would occur under other inhibitory conditions,
DO were cultured 4 h in medium containing dbcAMP,
8-AHA-cAMP, guanosine, hypoxanthine, or the oocyte-
specific cAMP phosphodiesterase inhibitor, milrinone (Tsa-
friri et al., 1996), in the presence or absence of 250 M
AICA riboside. These data are shown in Fig. 5. Under all
five inhibitory conditions, AICA riboside induced meiotic
maturation, with increases in GVB of 23–71%.
Since activation of AMP-activated kinase by AICA ribo-
side first requires phosphorylation of the adenosine analog
by adenosine kinase (Sabina et al., 1991), it was important
to test whether AICA riboside stimulation in mouse oo-
FIG. 2. Relationship between AICA riboside and adenosine with
the purine metabolic pathways. ZMP is an intermediate that forms
eight steps into the de novo purine synthetic pathway. AICA
riboside is metabolized by adenosine kinase (2) to ZMP that can
then feed directly into de novo purine synthesis. ZMP is also an
AMP analog and potent stimulator of AMPK. Adenosine is readily
phosphorylated to AMP by adenosine kinase (2) and further me-
tabolized by adenylate kinase (3) to other adenyl nucleotides.
Alternatively, adenosine is deaminated to inosine by adenosine
deaminase (1). Adenylate kinase is usually quite active and limits
the amount of AMP that can accumulate in cells.
FIG. 1. Western blot analysis of AMPK  subunit isoforms in
extracts of denuded oocytes (DO) and oocyte-cumulus cell com-
plexes (OCC). The number of DO and OCC used to load each lane
is shown in parentheses. The blots were probed with either an
antibody raised against the 1 isoform (a) or with an antibody raised
against the 2 isoform (b). The mobilities of molecular weight
markers are indicated on the right. The apparent higher molecular
weight of the AMPK 2 subunit in the OCC is thought to be due to
the high protein concentration in these samples. This does not
appear to be a problem for the 1 subunit since this protein
represents a much higher proportion of the total protein in these
samples.
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cytes is also dependent on its phosphorylation by this
enzyme. To this end, we used the adenosine kinase inhib-
itor, 5-amino-deoxyadenosine. DO were cultured 4 h in
medium containing 300 M dbcAMP  250 M AICA
riboside, and 5-amino-deoxyadenosine was added at 10
M, a concentration previously shown to block adenosine
phosphorylation in mouse OCC (Downs, 1999). AICA ribo-
side again induced a significant number of oocytes to
FIG. 3. Dose response effect of AICA riboside on GVB in dbcAMP- and hypoxanthine-arrested oocytes. DO (A) and CEO (B) were cultured
17–18 h in medium containing 300 m dbcAMP or 4 mM hypoxanthine (HX) plus increasing concentrations of AICA riboside. Oocytes
were then assessed for GVB. Each data point represents the mean  SEM of three determinations.
FIG. 4. Kinetics of AICA riboside-induced oocyte maturation. DO
or CEO were cultured for varying periods of time in medium
containing 300 m dbcAMP plus 250 (DO) or 1000 M (CEO) AICA
riboside. Oocytes were then assessed for GVB. Each data point
represents the mean of three determinations.
FIG. 5. Effect of AICA riboside on the maturation of DO in
different meiotic inhibitors. DO were cultured 4 h in medium
containing one of five different inhibitors: 300 M dbcAMP (dbc),
300 M 8-aminohexylamino-cAMP (8-AHA), 1 mM guanosine
(Guo), 4 mM hypoxanthine (HX), or 2 M milrinone  250 m
AICA riboside. Oocytes were then assessed for GVB. Each data
point represents the mean  SEM of three determinations. In all
treatment groups, AICA riboside stimulated a significant portion of
the oocytes to resume maturation, by Student’s t test.
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resume maturation (from 12 to 67% GVB; Fig. 6). While
5-amino-deoxyadenosine had no effect in the absence of
AICA riboside, the analog completely blocked AICA
riboside-induced maturation, consistent with the idea that
phosphorylation by adenosine kinase is required for its
meiosis-inducing activity.
Meiotic resumption in mammalian oocytes is normally
preceded by an increase in the activity of maturation-
promoting factor (MPF), comprised of regulatory cyclin
and catalytic p34cdc2 kinase subunits, which drives germ
cells through the G2/M transition (Nurse, 1990). To
determine whether AICA riboside acts upstream or
downstream of MPF, its action was tested on meiotic
inhibition imposed on DO by two established inhibitors
of the cyclin-dependent kinase, olomoucine (Vesely et
al., 1994; Abraham et al., 1995) and roscovitine (Meijer et
al., 1997). To this end, DO were cultured 4 h in medium
containing 400 M olomoucine or 50 M roscovitine in
the presence or absence of 250 M AICA riboside, while
dbcAMP-arrested DO served as a positive control. Both
olomoucine and roscovitine suppressed oocyte matura-
tion when compared to control oocytes, but AICA ribo-
side was unable to reverse the arrest by either inhibitor
(Fig. 7), although this agent stimulated GVB in dbcAMP-
arrested DO. These results suggest that AICA riboside
(and presumably AMPK) acts upstream in the cascade
leading to MPF activation.
To establish that AICA riboside is able to stimulate
AMPK activity in mouse oocytes, DO were cultured 4 h in
medium containing 300 M dbcAMP  AICA riboside and
then assayed for activity as described in Materials and
Methods, using a peptide substrate specific for the enzyme.
In the absence of AICA riboside, AMPK activity in
dbcAMP-treated oocytes was detected at a level of 0.043–
0.071 mU/100 oocytes (Fig. 8). While there was a trend
toward increased activity in response to 250 M AICA
riboside, this difference was not significant; however, sig-
nificant stimulation was observed with 500 M AICA
riboside (a 2.4-fold increase). These results demonstrate the
presence of AMPK activity in mouse oocytes and show it to
be a target for AICA riboside.
AMP and Oocyte Maturation
Since AICA riboside is thought to act on AMPK by its
conversion to an AMP analog, it was important to test the
action of native AMP on oocyte maturation. DO were
cultured 17–18 h in medium containing 300 M dbcAMP or
4 mM hypoxanthine, plus increasing concentrations of
AMP from 0.1 to 2 mM. As shown in Fig. 9, AMP dose-
dependently stimulated the resumption of maturation in
oocytes arrested by either inhibitor, with increases in GVB
of 21.4–24.6% at 2 mM.
To test the nucleotide specificity of this effect, DO were
maintained in meiotic arrest for 17–18 h by 300 M
dbcAMP and exposed to a series of nucleotides at 2 mM.
AMP again produced a significant stimulation of GVB (from
23.7 to 49.1%), but none of the other nucleotides was able
to mimic this effect (Fig. 10).
FIG. 7. Effect of AICA riboside in the presence of MPF inhibitors.
DO were cultured 4 h in control medium or medium containing
300 M dbcAMP (cAMP), 400 M olomoucine (Olo), or 50 M
roscovitine (Rosco), with AICA riboside added at a concentration of
250 M. Oocytes were then assessed for GVB. Each data point
represents the mean  SEM of three determinations. An asterisk
denotes a significant difference from the corresponding group
minus AICA riboside.
FIG. 6. Effect of inhibition of adenosine kinase on AICA riboside-
induced maturation. DO were cultured 4 h in medium containing
300 M dbcAMP  10 M 5-amino-deoxyadenosine (5-A-dAdo),
with AICA riboside added at a concentration of 250 M. Oocytes
were then assessed for GVB. Each data point represents the mean
SEM of three determinations.
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Monophosphate nucleotides might be susceptible to ecto-
5-nucleotidase or other phosphatases that could cleave the
phosphate from extracellular AMP and generate adenosine.
This is an important consideration, since adenosine is
readily taken up by cumulus cell-free oocytes (Downs et al.,
1986; Downs, 1999) and could conceivably mediate the
action of AMP on DO. Therefore, the effect of AMP on
oocyte maturation was tested in the presence of ,methyl-
ene ADP (MeADP), an inhibitor of 5-nucleotidase, and
-glycerophosphate, an inhibitor of nonspecific phosphatases.
DO were cultured 17–18 h in medium containing 300 M
dbcAMP 2 mM AMP, and MeADP and -glycerophosphate
were added at 100 M and 10 mM, respectively. The concen-
tration chosen for each inhibitor was dictated by a literature
search that determined them to be maximally effective in
other systems. AMP produced a modest stimulation of matu-
ration that was not significant. However, since the frequency
of maturation in the presence of AMP plus inhibitors was
significantly greater than that in their absence, it can be
concluded that the inhibitors failed to prevent AMP stimula-
tion of GVB (Fig. 11). The inhibitors also had no influence on
maturation in the absence of AMP.
The direct action of AMP on the oocyte suggests it is
taken up by germ cells and acts internally. To address
whether AMP is taken up by oocytes, DO were cultured
for 3 h in the presence of 3H-AMP and were collected at
hourly intervals to assess accumulation. A parallel group
of DO was cultured in the presence of MeADP and
-glycerophosphate. In a time-dependent fashion, oocytes
accumulated a significant amount of radiolabel, but this
was suppressed by 93% after the addition of phosphatase
inhibitors (Fig. 12). These results suggest that a major
portion of the uptake was indirect, resulting from meta-
bolic conversion of AMP to adenosine, although compe-
FIG. 8. Effect of AICA riboside on AMPK activity in DO. DO
were cultured 4 h in medium containing 300 m dbcAMP plus
either 250 or 500 m AICA riboside. Oocyte extracts were then
analyzed for AMPK activity. Each data point represents the mean
SEM of four determinations. An asterisk denotes a significant
difference by Student’s t test.
FIG. 9. Effect of AMP on dbcAMP- and hypoxanthine-maintained
meiotic arrest in DO. DO were cultured 17–18 h in medium containing
300 m dbcAMP or 4 mM hypoxanthine (HX) plus increasing concen-
trations of AMP. Oocytes were then assessed for GVB. Each data point
represents the mean  SEM of three (HX-treated) or five (dbcAMP-
treated) determinations. Groups from each inhibitor treatment were
analyzed separately by ANOVA followed by Duncan’s multiple range
test. Groups with no common letters are significantly different.
FIG. 10. Specificity of AMP-induced meiotic maturation in DO.
DO were cultured 17–18 h in medium containing 300 M dbcAMP
plus one of six different nucleotides at a concentration of 2 mM.
Oocytes were then assessed for GVB. Each data point represents the
mean  SEM of three determinations. Groups with no common
letters are significantly different.
206 Downs, Hudson, and Hardie
© 2002 Elsevier Science (USA). All rights reserved.
tition for the purine transporter cannot be discounted.
Nevertheless, uptake was still detected in the presence of
inhibitor, consistent with the idea that the oocyte has the
capacity to directly take up AMP.
Effect of the Combined Treatment of Adenosine
and Deoxycoformycin on Oocyte Maturation
Adenosine has consistently been shown in previous stud-
ies to exert a meiosis-arresting action on oocytes (Eppig et
al., 1985; Miller and Behrman, 1986; Tornell et al., 1990;
Salustri et al., 1988; Shim et al., 1992; Downs, 1999).
Nevertheless, it was hypothesized that blocking deamina-
tion of adenosine might cause an accumulation of AMP and
lead to AMPK activation, thereby stimulating meiotic re-
sumption (see Fig. 2). An experiment was therefore carried
out to determine whether the combined treatment of aden-
osine and the adenosine deaminase inhibitor, deoxycofor-
mycin (dCF), provided a stimulus for meiotic induction in
dbcAMP-arrested oocytes. CEO were cultured 17–18 h in
medium containing 150 M dbcAMP, plus 250 M adeno-
sine, 250 M dCF, or the two compounds together. As
shown in Fig. 13, neither adenosine nor dCF alone had a
significant effect on oocyte maturation. However, consis-
tent with the hypothesis, when these compounds were
added together, a significant increase in oocyte maturation
from 39 to 73.2% GVB was observed. The same experiment
was attempted with DO, but adenosine at similar concen-
trations proved toxic to the oocyte during overnight cul-
ture.
DISCUSSION
In this study, we report the presence of AMPK catalytic
subunits in mouse oocytes and OCC. In addition, through
FIG. 11. Effect of phosphatase inhibitors on AMP-induced mei-
otic maturation. DO were cultured 17–18 h in control medium or
medium containing 10 mM -glycerophosphate and 100 M ,-
methylene ADP,  2 mM AMP. Oocytes were then assessed for
GVB. Each data point represents the mean  SEM of six determi-
nations. Groups with no common letters are significantly different.
FIG. 12. Effect of phosphatase inhibitors on AMP uptake by DO.
DO were cultured for 1, 2, or 3 h in control medium or medium
containing 10 mM -glycerophosphate and 100 M ,-methylene
ADP, plus 10 Ci 3H-AMP. Uptake of AMP by oocytes was then
determined by scintillation spectroscopy. Each data point repre-
sents the mean  SEM of three determinations.
FIG. 13. Effect of adenosine and deoxycoformycin on dbcAMP-
maintained meiotic arrest. CEO were cultured 17–18 h in medium
containing 150 m dbcAMP alone, or dbcAMP plus 250 m
adenosine (Ado), 250 m deoxycoformycin (dCF), or the two agents
together. Oocytes were then assessed for GVB. Each data point
represents the mean  SEM of four determinations. Groups with
no common letters are significantly different .
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pharmacological activation of AMPK, a direct relationship
between enzyme activity and meiotic induction in arrested
oocytes has been demonstrated. Further evidence suggests
that an increase in oocyte AMP stimulates AMPK activity.
It is proposed that AMPK participates in meiotic induction
by its involvement in a metabolic cascade downstream of
PDE but upstream of MPF activation.
AMPK Is Present in OCC
Initial experiments demonstrated the presence of both 1
and 2 isoforms of AMPK in both the oocyte and cumulus
cells. While the tissue distribution of 1 appears to be
ubiquitous, 2 has been reported to be expressed principally
in liver and skeletal and cardiac muscle (Stapleton et al.,
1996). Thus, OCC can be added to the limited number of
tissues that express the 2 isoform. AMPK complexes
containing the 2 subunit have been shown to be partially
localized in the nucleus, while complexes containing the 1
subunit are located principally in the cytoplasm; in addi-
tion, 2-containing complexes are more responsive to AMP
than those containing 1 (Salt et al., 1998). Although both
isoforms are apparently present in oocytes, they may not
have equivalent potential for meiotic induction.
Evidence That AMPK Stimulates Meiotic
Resumption in Mouse Oocytes
As a potent activator of AMPK in intact cells (Sullivan et
al., 1994; Corton et al., 1995; Henin et al., 1995), AICA
riboside is an important pharmacological tool used for
assessing AMPK involvement in various physiological pro-
cesses. AICA riboside stimulation of both GVB and AMPK
activity in meiotically arrested mouse oocytes provides
compelling evidence that AMPK participates in meiotic
induction. Metabolic conversion of AICA riboside to the
AMP analog, AICA ribotide (ZMP), likely mediates its
meiosis-inducing action, since the adenosine kinase inhib-
itor, 5-aminodeoxyadenosine, completely blocked AICA
riboside-induced GVB. A physiological role for AMPK was
supported by the rapid kinetics of GVB: AICA riboside-
induced maturation in dbcAMP-arrested DO was initiated
within 3 h, a time frame similar to that observed in situ in
eCG-primed mice treated with hCG (Eppig and Downs,
1988). Moreover, AICA riboside action was not restricted by
the type of arresting agent, since this compound triggered
GVB in DO maintained in meiotic arrest by a wide variety
of inhibitory compounds. These included cAMP analogs,
hypoxanthine and milrinone, the latter an inhibitor of
oocyte-specific type III PDE (Tsafriri et al., 1996; Shit-
sukawa et al., 2001), which indicates that AMPK can
stimulate nuclear maturation under conditions that restrict
cAMP degradation and therefore suggests an action down-
stream of PDE.
Interestingly, higher concentrations of AICA riboside
were required to stimulate GVB in CEO. In fact, there was
an inhibitory trend at lower concentrations, which may be
due to metabolic conversion to purine nucleotides, since
AICA ribotide (ZMP) is a natural intermediate in the de
novo purine synthetic pathway (see Fig. 2). Indeed, AICA
riboside competes with 3H-glycine for purine nucleotide
production by OCC (Downs, 1997). No inhibition was
detected in DO at any concentration of AICA riboside, but
the nucleotide-producing capacity of the oocyte has yet to
be determined. The cellular target for the stimulatory
action of AICA riboside in the OCC cannot be discerned
from these data, but its high potency in DO makes the
oocyte a likely candidate. It may be that at high concentra-
tions a stimulatory action in the oocyte overrides a suppres-
sive action mediated by the cumulus cells.
In an earlier study (Downs, 1997), it was shown that
AICA riboside could overcome a block to follicle-
stimulating hormone- (FSH) induced meiotic maturation
brought about by inhibitors of purine de novo synthesis. It
was concluded that entry of AICA riboside into the de novo
purine synthetic pathway downstream of the block was
responsible for the restoration of meiotic resumption. How-
ever, in control groups lacking FSH, AICA riboside exhib-
ited a modest meiosis-inducing ability on its own that was
hard to reconcile in terms of de novo purine synthesis
(Downs, 1997). Based on the data obtained in the present
study, this AICA riboside effect on oocyte maturation in
the absence of FSH may have been due to stimulation of
AMPK.
Since AMP is a potent activator of AMPK (Moore et al.,
1991), dbcAMP- and hypoxanthine-arrested DO were ex-
posed to increasing concentrations of AMP to test for a
meiosis-inducing action. Under either inhibitory condition,
2 mM AMP stimulated more than 20% of the oocytes to
resume maturation. This result was not duplicated by other
nucleotides, nor was it due to ecto-5-nucleotidase or other
phosphatase activity. Such stimulation was somewhat sur-
prising, considering the polar nature of AMP and its pre-
sumed poor permeability through cell membranes. Never-
theless, uptake studies using 3H-AMP showed significant
accumulation by DO. Although the majority of uptake may
be attributable to initial extracellular conversion to adeno-
sine, significant uptake above background was consistently
detected in the presence of phosphatase inhibitors. Hence,
it is concluded that external AMP may enter the oocyte to
stimulate AMPK. It is doubtful that adenosine produced
from AMP enters the cells to mediate a positive action on
maturation, since oocytes exposed to this nucleoside ex-
hibit increased levels of ATP (Salustri et al., 1988) and
cAMP (Downs et al., 1989), conditions usually associated
with meiotic arrest. In addition, although we cannot elimi-
nate the possibility of an external effect of AMP or adeno-
sine via purinoceptor binding, such a mechanism seems
unlikely, because there is no precedence for a meiosis-
inducing action of these compounds at the oocyte surface.
On the contrary, it has been proposed that an oocyte
receptor-mediated mechanism contributes to a meiosis-
arresting action of adenosine (Salustri et al., 1988).
We recently showed that adenosine-suppressed matura-
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tion in hypoxanthine-treated CEO could be reversed by the
addition of the adenosine deaminase inhibitor, dCF
(Downs, 1999). It was concluded from this result that
adenosine deamination contributes to the meiosis-arresting
action of the nucleoside. However, results of the present
study have forced us to reevaluate the significance of these
earlier data. An alternative explanation is that blocking
adenosine deaminase did not suppress an inhibitory path-
way but, rather, turned on a positive pathway. Thus, at a
high adenosine concentration (250 M), phosphorylation of
AMP by adenylate kinase may become saturated, and with
the alternative deamination pathway blocked by dCF (see
Fig. 2), the resulting AMP accumulation brings about the
activation of AMPK and subsequent meiotic induction.
Such a mechanism has been demonstrated in cultured
hepatocytes for inhibition of autophagy (Samari and Seglen,
1998). Support for this mechanism in oocytes comes from
the finding that, when added to dbcAMP-containing me-
dium in the presence of dCF, adenosine actually stimulated
a significant increase in GVB. It should be stressed that this
response is uncharacteristic for adenosine, requiring the
presence of dCF and, thus, represents an alteration in
normal adenosine metabolism.
Is a Loss of Oocyte PKA Activity Required for
Meiotic Resumption?
If one assumes that (1) meiotic arrest requires the con-
tinuous activity of PKA and (2) the cAMP content of
germinal vesicle-stage oocytes at the time of isolation is
sufficient to maintain PKA activity at meiosis-arresting
levels, it necessarily follows that resumption of meiosis
would require a reduction in oocyte cAMP. However,
conditions exist in which meiotic maturation can resume
in mammalian oocytes without a decline in oocyte cAMP
below basal, presumably inhibitory, levels. For example,
Moor and Heslop (1981) reported an increase in sheep
oocyte cAMP in response to follicular stimulation by go-
nadotropin, but no decrease below fresh, nonstimulated
levels during the early stages of maturation. Racowsky
(1985) found that cAMP levels did not fall during release of
hamster CEO from forskolin-mediated meiotic arrest.
Treatment of mouse CEO with FSH (Salustri et al., 1985) or
a 2-h exposure of mouse follicles to forskolin (Hashimoto et
al., 1985) caused a transient rise in oocyte cAMP, but GVB
commenced before the cAMP returned to pretreatment
levels. This relationship was even more apparent in follicle-
enclosed rabbit oocytes exposed to hCG or forskolin (Yo-
shimura et al., 1992a,b), and these authors proposed that a
transient cAMP rise in both the somatic and germ cell
compartments is essential for effective meiotic induction.
Similar results with follicle-enclosed hamster oocytes led
Hubbard (1985, 1986) to conclude that maturation requires
an increase followed by a decline in oocyte cAMP. Interest-
ingly, a requirement for increased oocyte cAMP in meiotic
resumption has been demonstrated in lower forms such as
hydrozoans (Freeman and Ridgway, 1988), brittle stars (Ya-
mashita, 1988), and marine nemertean worms (Stricker and
Smythe, 2001), but this effect has been attributed to PKA
activity.
Such data in mammalian systems are difficult to recon-
cile solely in terms of PKA control of meiotic maturation.
Unless PKA can be inactivated by means other than low-
ered cAMP levels, meiotic maturation in the face of el-
evated cAMP suggests an alternative mechanism for mei-
otic resumption. The participation of AMPK in meiotic
induction provides an answer to these seemingly conflict-
ing data. A common finding in the above reports is that,
while the meiosis-inducing stimulus produces an increase
in oocyte cAMP, a significant drop in the peak cAMP level
precedes meiotic resumption, even though it may not fall
below the prestimulatory level. This fall in cAMP concen-
tration, mediated by oocyte PDE, could produce AMP at
levels above the stimulatory threshold required for AMPK
activation and lead to AMPK-induced GVB. Such activation
of AMPK would require PDE-mediated degradation of
cAMP, but not necessarily a reduction below that normally
associated with maintenance of meiotic arrest. Hence, GVB
might be triggered even with a background of active PKA, as
suggested by the actions of AICA riboside in oocytes
arrested by a variety of meiotic inhibitors, although high
levels of PKA activity may restrict AMPK effectiveness. In
addition, it should be noted that, even if oocyte cAMP
levels fall below the presumed inhibitory threshold, AMPK
may still contribute to the meiosis-inducing effect.
CONCLUSION
The results of this study show that the oocyte contains
AMPK that is activated coincidentally with GVB during
AICA riboside treatment. Further indirect evidence impli-
cates AMP, acting through AMPK, as having an important
meiosis-inducing function. A model for the participation of
AMPK in meiotic regulation that incorporates these obser-
vations is presented in Fig. 14.
Although AMPK is considered to be principally a stress-
response enzyme, the participation of this kinase family in
meiotic processes is not without precedence. In yeast,
fermentable carbon sources such as glucose block meiosis
through suppression of the AMPK homolog, SNF1; removal
of glucose from the culture medium activates the kinase
and drives yeast cells into meiosis (Mitchell, 1994; Kupiec
et al., 1997). Moreover, inactive snf1 mutants are incapable
of undergoing meiosis regardless of the presence or absence
of glucose (Carlson et al., 1981; Honigberg and Lee, 1998).
We have shown previously that when CEO are cultured in
medium containing a meiotic inhibitor plus millimolar
pyruvate, glucose exerts an inhibitory effect on meiotic
resumption that is dependent on glycolysis (Fagbohun and
Downs, 1992; Downs and Mastropolo, 1994; Downs,
1995b). It is tempting to speculate that, under these special
conditions, glycolytic generation of ATP lowers AMP/ATP
below the AMPK activation threshold and thereby contrib-
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utes to meiotic suppression. Such regulation by glucose
resembles that present in yeast and may represent a primi-
tive system for meiotic control. However, in complex
organisms, a more sophisticated means of meiotic control
has evolved that incorporates a hormone-triggered signal
cascade. AMPK may have been retained as a participant in
this process, but apparently with a different transduction
system, since hormone-stimulated maturation in mouse
CEO requires glucose (Fagbohun and Downs, 1992; Downs
and Mastropolo, 1994).
Evaluation of AMPK involvement in meiotic induction
promises to yield important new insights into how meiosis
is regulated. Confirmation of such involvement will neces-
sitate establishing where AMPK is situated in the cascade
of events leading to meiotic induction. It will be important
to determine whether increased AMPK activity precedes
and is essential for ligand-induced, as well as spontaneous,
maturation, not only in the mouse but in other species as
well. Even if it proves not to be required for normal meiotic
induction, its presence in the oocyte indicates a mechanism
for the oocyte to respond to stressful conditions. In addi-
tion, it is anticipated that the recent development of
AMPK-specific inhibitors (e.g., Zhou et al., 2001) and other
molecular and pharmacological tools will facilitate a thor-
ough examination of the physiological role of AMPK in
meiosis.
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